A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet‐derived growth factor receptor‐α or ‐β
暂无分享,去创建一个
P. Casali | S. Ferrari | S. Stacchiotti | M. Aglietta | V. Ferraresi | G. Grignani | E. Palmerini | A. Comandone | S. Frustaci | A. Boglione